Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 1.0
PALISADE BIO, INC. entered into Securities Purchase Agreement with certain institutional investors valued at 2,339,398 shares at $0.84 per share for aggregate gross proceeds of approximately $1.97 million (effective 2023-09-07).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- certain institutional investors
- Value
- 2,339,398 shares at $0.84 per share for aggregate gross proceeds of approximately $1.97 million
- Effective
- 2023-09-07
Exact text from the filing
Entry into a Material Definitive Agreement. Registered Direct Offering of Shares On September 7, 2023, Palisade Bio, Inc. (the “Company”) entered into securities purchase agreements (the “Purchase Agreements”) with certain institutional investors (the “Purchasers”), pursuant to which the Company agreed to sell and issue an aggregate of 2,339,398 shares (the “Shares”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”), at a purchase price per share of $0.84 (the “Offering”).
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 1.0
PALISADE BIO, INC. entered into Placement Agency Agreement with Ladenburg Thalmann & Co. Inc. valued at cash fee equal to 7.75% of gross proceeds, payment of up to $95,000 for certain expenses, and warran (effective 2023-09-07).
- Action
- entry
- Agreement
- underwriting
- Counterparty
- Ladenburg Thalmann & Co. Inc.
- Value
- cash fee equal to 7.75% of gross proceeds, payment of up to $95,000 for certain expenses, and warran
- Effective
- 2023-09-07
Exact text from the filing
In connection with the Offering, we entered into a placement agency agreement (“Placement Agency Agreement”) with Ladenburg Thalmann & Co. Inc. (“Placement Agent”) whereby the Placement Agent receives (i) an aggregate cash fee equal to 7.75% of the gross proceeds received by the Company from the sale of the Shares, (ii) payment of up to $95,000 for certain expenses incurred in the Offering, and (iii) warrants to purchase up to 6.0% of the aggregate Shares sold in the Offering, or an aggregate of 140,364 placement agent warrants (the “Placement Agent Warrants”).
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 1.0
PALISADE BIO, INC. entered into Placement Agent Warrants with Ladenburg Thalmann & Co. Inc. valued at 140,364 warrants, term of five years, exercise price of $1.05 per share (effective 2023-09-07).
- Action
- entry
- Counterparty
- Ladenburg Thalmann & Co. Inc.
- Value
- 140,364 warrants, term of five years, exercise price of $1.05 per share
- Effective
- 2023-09-07
Exact text from the filing
The Placement Agent Warrants have a term of five (5) years from the commencement of sales, an exercise price of $1.05 per share, and are not being registered pursuant to this Offering.
View on SEC.gov